应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01167 加科思-B
休市中 08-23 16:08:27
1.520
+0.020
+1.33%
最高
1.530
最低
1.460
成交量
19.11万
今开
1.510
昨收
1.500
日振幅
4.67%
总市值
12.00亿
流通市值
12.00亿
总股本
7.89亿
成交额
28.52万
换手率
0.02%
流通股本
7.89亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
加科思重磅药物宣布终止研发
健识局 · 08-23 19:52
加科思重磅药物宣布终止研发
加科思放弃一代SHP2抑制剂
生物制药小编 · 08-23 09:20
加科思放弃一代SHP2抑制剂
劲方KRAS抑制剂获批!信达、正大天晴商业化大战在即,加科思如何撕开口子?
医药经济报 · 08-22 19:55
劲方KRAS抑制剂获批!信达、正大天晴商业化大战在即,加科思如何撕开口子?
加科思-B盘中异动 下午盘股价大跌5.06%报1.520港元
市场透视 · 08-22
加科思-B盘中异动 下午盘股价大跌5.06%报1.520港元
加科思-B(01167.HK)拟8月30日举行董事会会议审批中期业绩
格隆汇 · 08-20
加科思-B(01167.HK)拟8月30日举行董事会会议审批中期业绩
加科思-B盘中异动 股价大跌7.88%
自选股智能写手 · 08-19
加科思-B盘中异动 股价大跌7.88%
加科思-B盘中异动 下午盘快速拉升5.26%
自选股智能写手 · 08-15
加科思-B盘中异动 下午盘快速拉升5.26%
加科思-B盘中异动 股价大跌5.33%
自选股智能写手 · 08-13
加科思-B盘中异动 股价大跌5.33%
加科思-B(01167)股价下跌7.186%,现价港币$1.55
阿斯达克财经 · 08-13
加科思-B(01167)股价下跌7.186%,现价港币$1.55
加科思(01167):完成JAB-3312与Glecirasib联用三期临床首例患者给药
金吾财讯 · 08-07
加科思(01167):完成JAB-3312与Glecirasib联用三期临床首例患者给药
加科思-B(01167)完成JAB-3312与Glecirasib 联用注册性三期临床研究首例患者给药
智通财经 · 08-07
加科思-B(01167)完成JAB-3312与Glecirasib 联用注册性三期临床研究首例患者给药
加科思-B盘中异动 下午盘股价大跌6.30%报1.621港元
自选股智能写手 · 08-07
加科思-B盘中异动 下午盘股价大跌6.30%报1.621港元
加科思-B08月05日遭主力抛售22万元 环比增加144.44%
自选股智能写手 · 08-05
加科思-B08月05日遭主力抛售22万元 环比增加144.44%
加科思-B盘中异动 下午盘快速下挫5.23%报1.630港元
自选股智能写手 · 08-05
加科思-B盘中异动 下午盘快速下挫5.23%报1.630港元
加科思-B(01167)股价下跌5.233%,现价港币$1.63
阿斯达克财经 · 08-05
加科思-B(01167)股价下跌5.233%,现价港币$1.63
加科思-B盘中异动 股价大涨5.49%
自选股智能写手 · 07-31
加科思-B盘中异动 股价大涨5.49%
加科思-B(01167)股价上升5.556%,现价港币$1.71
阿斯达克财经 · 07-31
加科思-B(01167)股价上升5.556%,现价港币$1.71
加科思-B(01167)股价下跌5.294%,现价港币$1.61
阿斯达克财经 · 07-23
加科思-B(01167)股价下跌5.294%,现价港币$1.61
加科思-B盘中异动 股价大跌5.08%报1.680港元
自选股智能写手 · 07-19
加科思-B盘中异动 股价大跌5.08%报1.680港元
加科思-B(01167)上涨8.05%,报1.88元/股
金融界 · 07-15
加科思-B(01167)上涨8.05%,报1.88元/股
加载更多
公司概况
公司名称:
加科思-B
所属市场:
SEHK
上市日期:
--
主营业务:
加科思药业集团有限公司是一家主要从事临床阶段新药研发的中国投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01167","market":"HK","secType":"STK","nameCN":"加科思-B","latestPrice":1.52,"timestamp":1724400507027,"preClose":1.5,"halted":0,"volume":191100,"delay":0,"floatShares":789419880,"shares":789419880,"eps":-0.509201,"marketStatus":"休市中","marketStatusCode":7,"change":0.02,"latestTime":"08-23 16:08:27","open":1.51,"high":1.53,"low":1.46,"amount":285237,"amplitude":0.046667,"askPrice":1.52,"askSize":43500,"bidPrice":1.48,"bidSize":1200,"shortable":0,"etf":0,"ttmEps":-0.5092010076327547,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"listingDate":1608480000000,"adjPreClose":1.5,"openAndCloseTimeList":[[1724376600000,1724385600000],[1724389200000,1724400000000]],"volumeRatio":0.8468492419976471,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01167","defaultTab":"news","newsList":[{"id":"2461983945","title":"加科思重磅药物宣布终止研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2461983945","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461983945?lang=zh_cn&edition=full","pubTime":"2024-08-23 19:52","pubTimestamp":1724413952,"startTime":"0","endTime":"0","summary":"8月21日,加科思发布2023中报及2023年报的补充公告,其中提到终止SHP2变构抑制剂JAB-3068的临床开发。针对这一靶点,加科思布局领先,JAB-3068是全球第二个进入临床阶段的SHP2抑制剂,此前已进入到二期临床阶段。接二连三的退货事件,再加上此次的加科思的终止研发,再度给SHP2抑制剂的未来带来了一丝不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408232001019f4c3b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408232001019f4c3b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2461231307","title":"加科思放弃一代SHP2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2461231307","media":"生物制药小编","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461231307?lang=zh_cn&edition=full","pubTime":"2024-08-23 09:20","pubTimestamp":1724376046,"startTime":"0","endTime":"0","summary":"近日,加科思发布一则2023中期报告及2023年度报告的补充公告,公司已决终止JSHP2变构抑制剂JAB-3068的临床开发。JAB-3068是全球第二个进入临床阶段的SHP2抑制剂,此前已推进至临床II期阶段。SHP2和KRAS一样,曾都是难以成药的靶点,目前依旧没有任何SHP2抑制剂获得批准上市。虽然加科思放弃了JAB-3068,但是已经把另外一款SHP2抑制剂JAB-3312推到全球领先的位置,通过与KRAS G12C抑制剂的联用,有望成为第一家推出全球第一款上市SHP2抑制剂的制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082309440195b60a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082309440195b60a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2461319393","title":"劲方KRAS抑制剂获批!信达、正大天晴商业化大战在即,加科思如何撕开口子?","url":"https://stock-news.laohu8.com/highlight/detail?id=2461319393","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461319393?lang=zh_cn&edition=full","pubTime":"2024-08-22 19:55","pubTimestamp":1724327701,"startTime":"0","endTime":"0","summary":"值得一提的是,氟泽雷塞也是国内首个获批上市的KRAS G12C抑制剂。自安进的Sotorasib率先获批上市以来,KRAS G12C抑制剂便迎来了研发热潮,目前相关布局的药企正步入收获期。KRAS G12C抑制剂的出现,为治疗携带该基因突变的癌症患者开辟了精准治疗的方向。直至安进的Sotorasib作为全球首个KRAS G12C抑制剂获批上市,该魔咒才被一举打破。通过与信达生物的合作推进,从2018年就已立项的劲方医药此番拿下了国内首个获批上市的KRAS G12C抑制剂的殊荣。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408222024269f47fd58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408222024269f47fd58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","LU2328871848.SGD","BK1574","BK1161","01801","LU1969619763.USD","09939","01167","LU2488822045.USD","09688","BK1515","BK1589","BK1583"],"gpt_icon":0},{"id":"2461153357","title":"加科思-B盘中异动 下午盘股价大跌5.06%报1.520港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461153357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461153357?lang=zh_cn&edition=full","pubTime":"2024-08-22 14:37","pubTimestamp":1724308671,"startTime":"0","endTime":"0","summary":"2024年08月22日下午盘14时37分,加科思-B股票出现异动,股价大幅下挫5.06%。截至发稿,该股报1.520港元/股,成交量23.4万股,换手率0.03%,振幅6.25%。资金方面,该股资金流入4.5558万港元,流出29.9268万港元。加科思-B股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,同源康医药-B、北海康成-B、来凯医药-B涨幅较大,振幅较大的相关个股有同源康医药-B、来凯医药-B、迈博药业-B,振幅分别为16.46%、15.71%、12.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822143751ab5f006a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822143751ab5f006a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1161","BK1574"],"gpt_icon":0},{"id":"2460241010","title":"加科思-B(01167.HK)拟8月30日举行董事会会议审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241010","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241010?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:48","pubTimestamp":1724143702,"startTime":"0","endTime":"0","summary":"格隆汇8月20日丨加科思-B(01167.HK)公告,谨定于2024年8月30日(星期五)举行董事会会议,以审议及批准(其中包括)公司及其附属公司截至2024年6月30日止6个月度中期业绩及其发布,以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820164822ab5e921c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820164822ab5e921c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1161","BK1574"],"gpt_icon":0},{"id":"2460729769","title":"加科思-B盘中异动 股价大跌7.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460729769","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460729769?lang=zh_cn&edition=full","pubTime":"2024-08-19 09:30","pubTimestamp":1724031057,"startTime":"0","endTime":"0","summary":"2024年08月19日早盘09时30分,加科思-B股票出现异动,股价快速跳水7.88%。截至发稿,该股报1.520港元/股,成交量600股,换手率0.00%,振幅0.00%。加科思-B股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,康希诺生物、再鼎医药、药明合联涨幅较大,振幅较大的相关个股有晶泰科技、圣诺医药-B、康希诺生物,振幅分别为4.69%、2.56%、2.28%。加科思-B公司简介:加科思药业集团有限公司是一家主要从事临床阶段新药研发的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819093057a1d4e25e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819093057a1d4e25e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01167","BK1574"],"gpt_icon":0},{"id":"2459496622","title":"加科思-B盘中异动 下午盘快速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459496622","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459496622?lang=zh_cn&edition=full","pubTime":"2024-08-15 13:00","pubTimestamp":1723698014,"startTime":"0","endTime":"0","summary":"2024年08月15日下午盘13时00分,加科思-B股票出现波动,股价快速上涨5.26%。截至发稿,该股报1.621港元/股,成交量6.39万股,换手率0.01%,振幅5.19%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。其相关个股中,欧康维视生物-B、加科思-B、科济药业-B涨幅较大,振幅较大的相关个股有晶泰科技、中国抗体-B、华康生物医学,振幅分别为15.34%、11.61%、9.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815130014aefecec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815130014aefecec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1161","BK1574"],"gpt_icon":0},{"id":"2459972889","title":"加科思-B盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459972889","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459972889?lang=zh_cn&edition=full","pubTime":"2024-08-13 10:19","pubTimestamp":1723515557,"startTime":"0","endTime":"0","summary":"2024年08月13日早盘10时19分,加科思-B股票出现异动,股价急速下跌5.33%。截至发稿,该股报1.581港元/股,成交量4.41万股,换手率0.01%,振幅1.20%。加科思-B股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,维亚生物、科笛-B、百奥赛图-B涨幅较大,振幅较大的相关个股有欧康维视生物-B、永泰生物-B、奥星生命科技,振幅分别为15.28%、9.65%、8.57%。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081310191896825ee1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081310191896825ee1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2459997721","title":"加科思-B(01167)股价下跌7.186%,现价港币$1.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2459997721","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459997721?lang=zh_cn&edition=full","pubTime":"2024-08-13 10:19","pubTimestamp":1723515540,"startTime":"0","endTime":"0","summary":"[下跌股]加科思-B(01167) 股价在上午10:19比前收市价下跌7.186%,现股价为港币$1.55。至目前为止,今日最高价为$1.62,而最低价为$1.55。总成交量为4.47万股,总成交金额为港币$7.18万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240813620/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2457550897","title":"加科思(01167):完成JAB-3312与Glecirasib联用三期临床首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2457550897","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457550897?lang=zh_cn&edition=full","pubTime":"2024-08-07 17:27","pubTimestamp":1723022842,"startTime":"0","endTime":"0","summary":"金吾财讯 | 加科思(01167)公布,公司自主研发的SHP2抑制剂JAB-3312与KRASG12C抑制剂Glecirasib联合用药用于KRASG12C突变的一线非小细胞肺癌(NSCLC)对照标准疗法(PD-1抗体和化疗联合治疗)的注册性三期临床试验已完成首例患者给药。JAB-3312是全球首个进入注册性临床试验的SHP2抑制剂。据悉,Glecirasib单药用于KRASG12C突变二线非小细胞肺癌的新药上市申请(NDA)已于2024年5月21日已被中国国家药品监督管理局(NMPA)药品审评中心(CDE)获批优先审评。","market":"other","thumbnail":"https://static.szfiu.com/news/20200915/N2IzYTRmMmIxMTYzYjFlNzAzMjUwMDIzMzk5Mjk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/N2IzYTRmMmIxMTYzYjFlNzAzMjUwMDIzMzk5Mjk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1941869","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2457899050","title":"加科思-B(01167)完成JAB-3312与Glecirasib 联用注册性三期临床研究首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2457899050","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457899050?lang=zh_cn&edition=full","pubTime":"2024-08-07 16:41","pubTimestamp":1723020077,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B 发布公告,公司自主研发的SHP2抑制剂 JAB-3312与KRAS G12C抑制剂Glecirasib联合用药用于KRAS G12C突变的一线非小细胞肺癌对照标准疗法的注册性三期临床试验已完成首例患者给药。JAB-3312是全球首个进入注册性临床试验的SHP2抑制剂。Glecirasib单药用于KRAS G12C突变二线非小细胞肺癌的新药上市申请已于2024年5月21日已被中国国家药品监督管理局药品审评中心获批优先审评。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1161059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2457850022","title":"加科思-B盘中异动 下午盘股价大跌6.30%报1.621港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457850022","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457850022?lang=zh_cn&edition=full","pubTime":"2024-08-07 13:26","pubTimestamp":1723008412,"startTime":"0","endTime":"0","summary":"2024年08月07日下午盘13时26分,加科思-B股票出现波动,股价大幅下挫6.30%。截至发稿,该股报1.621港元/股,成交量5.61万股,换手率0.01%,振幅2.89%。资金方面,该股资金流入0港元,流出9.1938万港元。其相关个股中,绿竹生物-B、晶泰科技、再鼎医药涨幅较大,振幅较大的相关个股有晶泰科技、北海康成-B、来凯医药-B,振幅分别为13.03%、10.87%、9.92%。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080713265396824a1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080713265396824a1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2457743859","title":"加科思-B08月05日遭主力抛售22万元 环比增加144.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457743859","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457743859?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:16","pubTimestamp":1722845769,"startTime":"0","endTime":"0","summary":"08月05日, 加科思-B股价跌2.91%,报收1.67元,成交金额88万元,换手率0.07%,振幅8.72%,量比3.52。加科思-B今日主力资金净流出22万元,上一交易日主力净流出9万元,今日环比增加144.44%。该股近5个交易日上涨1.83%,主力资金累计净流出23万元;近20日主力资金累计净流入56万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805161649957e6d4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805161649957e6d4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2457718100","title":"加科思-B盘中异动 下午盘快速下挫5.23%报1.630港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457718100","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457718100?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:59","pubTimestamp":1722837578,"startTime":"0","endTime":"0","summary":"2024年08月05日下午盘13时59分,加科思-B股票出现波动,股价急速跳水5.23%。截至发稿,该股报1.630港元/股,成交量22.26万股,换手率0.03%,振幅6.40%。资金方面,该股资金流入10.0647万港元,流出18.2922万港元。加科思-B股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,嘉和生物-B、泰格医药、乐普生物-B涨幅较大,振幅较大的相关个股有乐普生物-B、方达控股、宜明昂科-B,振幅分别为19.00%、17.28%、16.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805135938af95e101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805135938af95e101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2457713620","title":"加科思-B(01167)股价下跌5.233%,现价港币$1.63","url":"https://stock-news.laohu8.com/highlight/detail?id=2457713620","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457713620?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:59","pubTimestamp":1722837540,"startTime":"0","endTime":"0","summary":"[下跌股]加科思-B(01167) 股价在下午01:59比前收市价下跌5.233%,现股价为港币$1.63。至目前为止,今日最高价为$1.74,而最低价为$1.63。总成交量为21万股,总成交金额为港币$35.754万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2408053910/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2455220859","title":"加科思-B盘中异动 股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455220859","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455220859?lang=zh_cn&edition=full","pubTime":"2024-07-31 13:05","pubTimestamp":1722402322,"startTime":"0","endTime":"0","summary":"2024年07月31日下午盘13时05分,加科思-B股票出现异动,股价大幅拉升5.49%。截至发稿,该股报1.710港元/股,成交量9.54万股,换手率0.01%,振幅4.32%。加科思-B股票所在的生物技术行业中,整体涨幅为1.74%。其相关个股中,科笛-B、药明合联、药明生物涨幅较大,振幅较大的相关个股有维亚生物、华康生物医学、方达控股,振幅分别为16.00%、14.79%、14.08%。加科思-B公司简介:加科思药业集团有限公司是一家主要从事临床阶段新药研发的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073113052296822237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073113052296822237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2455924011","title":"加科思-B(01167)股价上升5.556%,现价港币$1.71","url":"https://stock-news.laohu8.com/highlight/detail?id=2455924011","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455924011?lang=zh_cn&edition=full","pubTime":"2024-07-31 13:05","pubTimestamp":1722402300,"startTime":"0","endTime":"0","summary":"[上升股]加科思-B(01167) 股价在下午01:05比前收市价上升5.556%,现股价为港币$1.71。至目前为止,今日最高价为$1.71,而最低价为$1.64。总成交量为9.54万股,总成交金额为港币$15.917万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407314757/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2453706259","title":"加科思-B(01167)股价下跌5.294%,现价港币$1.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2453706259","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453706259?lang=zh_cn&edition=full","pubTime":"2024-07-23 14:57","pubTimestamp":1721717820,"startTime":"0","endTime":"0","summary":"[下跌股]加科思-B(01167) 股价在下午02:57比前收市价下跌5.294%,现股价为港币$1.61。至目前为止,今日最高价为$1.72,而最低价为$1.61。总成交量为8.67万股,总成交金额为港币$14.447万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407231816/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2452368446","title":"加科思-B盘中异动 股价大跌5.08%报1.680港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452368446","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452368446?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:46","pubTimestamp":1721375208,"startTime":"0","endTime":"0","summary":"2024年07月19日临近收盘15时46分,加科思-B股票出现波动,股价大幅下挫5.08%。截至发稿,该股报1.680港元/股,成交量25.56万股,换手率0.03%,振幅4.52%。资金方面,该股资金流入14.3154万港元,流出28.1952万港元。加科思-B股票所在的生物技术行业中,整体跌幅为0.71%。其相关个股中,创胜集团-B、泰格医药、友芝友生物-B涨幅较大,振幅较大的相关个股有华领医药-B、华康生物医学、锦欣生殖,振幅分别为20.00%、17.59%、14.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719154648af931e13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719154648af931e13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2451650614","title":"加科思-B(01167)上涨8.05%,报1.88元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451650614","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451650614?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:37","pubTimestamp":1721007470,"startTime":"0","endTime":"0","summary":"7月15日,加科思-B(01167)盘中上涨8.05%,截至09:37,报1.88元/股,成交106.02万元。加科思药业集团有限公司是一家专注于临床阶段新药研发,特别是创新肿瘤疗法的自主发现和开发的中国投资控股公司。其主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂,并主要在国内市场开展业务。截至2023年年报,加科思-B营业总收入6352.0万元、净利润-3.59亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/15093741565419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","01167","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jacobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0788},{"period":"1month","weight":-0.0559},{"period":"3month","weight":-0.2},{"period":"6month","weight":-0.3745},{"period":"1year","weight":-0.601},{"period":"ytd","weight":-0.5801}],"compareEarnings":[{"period":"1week","weight":0.0104},{"period":"1month","weight":0.0174},{"period":"3month","weight":-0.0536},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0329},{"period":"ytd","weight":0.0331}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"加科思药业集团有限公司是一家主要从事临床阶段新药研发的中国投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.005532},{"month":2,"riseRate":0.25,"avgChangeRate":0.053851},{"month":3,"riseRate":0,"avgChangeRate":-0.187604},{"month":4,"riseRate":0.75,"avgChangeRate":0.048427},{"month":5,"riseRate":0.25,"avgChangeRate":-0.044098},{"month":6,"riseRate":0,"avgChangeRate":-0.038854},{"month":7,"riseRate":0.25,"avgChangeRate":-0.142126},{"month":8,"riseRate":0.25,"avgChangeRate":-0.006089},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.12321},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.013633},{"month":11,"riseRate":0.333333,"avgChangeRate":0.071626},{"month":12,"riseRate":0.333333,"avgChangeRate":0.002401}],"exchange":"SEHK","name":"加科思-B","nameEN":"JACOBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加科思-B,01167,加科思-B股票,加科思-B股票老虎,加科思-B股票老虎国际,加科思-B行情,加科思-B股票行情,加科思-B股价,加科思-B股市,加科思-B股票价格,加科思-B股票交易,加科思-B股票购买,加科思-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}